Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Cancer|April 23, 2014
Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non-muscle-invasive bladder cancerBassel G Bachir, Alice Dragomir, Armen G Aprikian, et al.
Molecular Cancer Research : MCR|October 11, 2017
Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome after Surgical InterventionYogesh M Bramhecha, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Journal of the American Heart Association|June 20, 2019
Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and NeckJacinthe Boulet, Jessica Peña, Edward A Hulten, et al.
Frontiers in Pharmacology|January 31, 2022
Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial FibrillationSylvie Perreault, Alice Dragomir, Robert Côté, et al.
British Journal of Cancer|February 3, 2017
Asporin is a stromally expressed marker associated with prostate cancer progressionAnnie Rochette, Nadia Boufaied, Eleonora Scarlata, et al.
Pharmacotherapy|February 5, 2021
Comparative effectiveness and safety of high-dose rivaroxaban and apixaban for atrial fibrillation: A propensity score-matched cohort studySylvie Perreault, Alice Dragomir, Robert Côté, et al.
CMAJ Open|December 13, 2017
Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational studyAlice Dragomir, Armen Aprikian, Anil Kapoor, et al.
Clinical Drug Investigation|September 30, 2018
Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world EvidenceSara Nazha, Simon Tanguay, Anil Kapoor, et al.
Urologic Oncology|August 12, 2020
Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experienceAlice Dragomir, Sara Nazha, Lori A Wood, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective TrialsYasir Alayed, Melanie Davidson, Stanley Liu, et al.
Pageof 8